ArticleJournal of clinical psychopharmacology2018

A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults.

Cynthia Richards et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.